Asembia, a leader in specialty pharmaceutical services, and Outcomes, a premier clinical engagement platform, are proud to announce a strategic partnership that brings together their strengths to ...

When I had bought 3 series, I had enquired about ES300 and had dropped due to various reasons. Last year there were juicy ...

The retailer told an appeals court that it didn’t illegally conceal a federal investigation into its shady opioid ...

Health enthusiasts and biohackers are shifting toward plant-based, glucose-regulating supplements that focus on holistic wellness. Products like Sugar Defender are catching attention because they ...

UnitedHealth is the parent company of Optum Rx, one of the biggest PBMs. A PBM helps employer-sponsored health plans and ...

Vincerx Pharma (VINC) announced its intention to file a Form 25 Notification of Delisting with the SEC on or about April 28, which will remove ...

Key Takeaways Eli Lilly's oral GLP-1 pill helped patients regulate blood sugar and lose weightThe drug reduced weight by 16 ...

Google has decided to demo Android XR on a prototype of its glasses, just to show people what it can do. Check out this ...

Vincerx common stock suspended by Nasdaq inadvertently; will resume trading at the open of business on April 21, 2025 Trading to be permanently ...

Survey reveals 47% of remote workers fear layoffs in 2025, with Gen Z most concerned about job security over career growth.

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...